Alastin Skincare Receives Patent for Topical Composition

Posted By American Med Spa Association, Wednesday, July 22, 2020

Alastin Skincare, Inc.—a specialty aesthetics company dedicated to developing and marketing clinically tested, physician-dispensed skin care products—has announced that the United States Patent and Trademark Office has issued a fourth U.S. Patent, No. 10,688,147, incorporating Alastin's platform TriHex Technology. The patent is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum with TriHex Technology.
Read more at PR Newswire >>